Pertussis (Whooping Cough)
Author:
Affiliation:
1. Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA
2. Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Abstract
Funder
Bill and Melinda Gates Foundation
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Immunology and Allergy
Link
http://academic.oup.com/jid/article-pdf/224/Supplement_4/S310/40481467/jiaa469.pdf
Reference15 articles.
1. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990–1996;Guris;Clin Infect Dis,1999
2. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model;Warfel;Proc Natl Acad Sci USA,2014
3. Comparison of 13 acellular pertussis vaccines: adverse reactions;Decker;Pediatrics,1995
4. Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine;Howson;JAMA,1992
5. Comparison of 13 acellular pertussis vaccines: overview and serologic response;Edwards;Pediatrics,1995
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cost of illness due to pertussis in adults ≥50 years of age in the United Kingdom;Vaccine;2023-11
2. Performance of targeted next-generation sequencing in the detection of respiratory pathogens and antimicrobial resistance genes for children;Journal of Medical Microbiology;2023-11-01
3. The Present and Future Aspects of Life-Long Pertussis Prevention: Narrative Review with Regional Perspectives for Türkiye;Infectious Diseases and Therapy;2023-10-10
4. A study of acceptance and hesitation factors towards tetanus, diphtheria, and acellular pertussis (Tdap) and influenza vaccines during pregnancy;Vaccine: X;2023-08
5. A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women;Vaccine;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3